WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011160146) PHARMACEUTICAL PREPARATION CONTAINING DEXTRAN AND SODIUM HYALURONATE FOR THE TREATMENT OF JOINT DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/160146    International Application No.:    PCT/AT2011/000269
Publication Date: 29.12.2011 International Filing Date: 16.06.2011
IPC:
A61K 31/721 (2006.01), A61K 31/728 (2006.01), A61P 19/02 (2006.01)
Applicants: CROMA-PHARMA GESELLSCHAFT M.B.H. [AT/AT]; Industriezeile 6 A-2100 Korneuburg (AT) (For All Designated States Except US).
HORNOF, Margit [AT/AT]; (AT) (For US Only).
PRINZ, Martin [AT/AT]; (AT) (For US Only)
Inventors: HORNOF, Margit; (AT).
PRINZ, Martin; (AT)
Agent: SCHWARZ, Albin; Schwarz & Partner Wipplingerstrasse 30 A-1010 Wien (AT)
Priority Data:
A 1055/2010 23.06.2010 AT
Title (EN) PHARMACEUTICAL PREPARATION CONTAINING DEXTRAN AND SODIUM HYALURONATE FOR THE TREATMENT OF JOINT DISORDERS
(FR) PRÉPARATION PHARMACEUTIQUE CONTENANT DU DEXTRANE ET DE L'HYALURONATE DE SODIUM POUR LE TRAITEMENT DE TROUBLES ARTICULAIRES
Abstract: front page image
(EN)Pharmaceutical preparation for intraarticular injection for treating inflammatory and degenerative joint disorders containing 0.2-32% (m/v) dextran with an average molecular weight of 500 to 3,000 Da and 0.1-10% sodium hyaluronate with an average molecular weight of 500,000 to 3500,000 Da, with the proviso that no further dextran having an average molecular weight in the range of 30,000 and 110,000 Da is contained.
(FR)L'invention porte sur une préparation pharmaceutique pour injection intra-articulaire pour le traitement de troubles articulaires inflammatoires et dégénératifs contenant 0,2-32 % (m/v) de dextrane présentant une masse moléculaire moyenne de 500 à 3 000 Da et 0,1-10 % d'hyaluronate de sodium présentant une masse moléculaire moyenne de 500 000 à 3 500 000 Da, à condition qu'elle ne contienne pas d'autre dextrane présentant une masse moléculaire moyenne dans la plage de 30 000 à 110 000 Da.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)